139 related articles for article (PubMed ID: 36219493)
41. Rational design of pH-activated upconversion luminescent nanoprobes for bioimaging of tumor acidic microenvironment and the enhancement of photothermal therapy.
Tan B; Zhao C; Wang J; Tiemuer A; Zhang Y; Yu H; Liu Y
Acta Biomater; 2023 Jan; 155():554-563. PubMed ID: 36087865
[TBL] [Abstract][Full Text] [Related]
42. Manganese/iron-based nanoprobes for photodynamic/chemotherapy combination therapy of tumor guided by multimodal imaging.
Fan S; Zhang Y; Tan H; Xue C; He Y; Wei X; Zha Y; Niu J; Liu Y; Cheng Y; Cui D
Nanoscale; 2021 Mar; 13(10):5383-5399. PubMed ID: 33666213
[TBL] [Abstract][Full Text] [Related]
43. Tumor microenvironment-activated therapeutic peptide-conjugated prodrug nanoparticles for enhanced tumor penetration and local T cell activation in the tumor microenvironment.
Zhu X; Li C; Lu Y; Liu Y; Wan D; Zhu D; Pan J; Ma G
Acta Biomater; 2021 Jan; 119():337-348. PubMed ID: 33166712
[TBL] [Abstract][Full Text] [Related]
44. Ultra-thin layered double hydroxide-mediated photothermal therapy combine with asynchronous blockade of PD-L1 and NR2F6 inhibit hepatocellular carcinoma.
Lu YF; Zhou JP; Zhou QM; Yang XY; Wang XJ; Yu JN; Zhang JG; Du YZ; Yu RS
J Nanobiotechnology; 2022 Jul; 20(1):351. PubMed ID: 35907841
[TBL] [Abstract][Full Text] [Related]
45. Tumor microenvironment-responsive polydopamine-based core/shell nanoplatform for synergetic theranostics.
Chen Q; Shan X; Shi S; Jiang C; Li T; Wei S; Zhang X; Sun G; Liu J
J Mater Chem B; 2020 May; 8(18):4056-4066. PubMed ID: 32270145
[TBL] [Abstract][Full Text] [Related]
46. A dual-targeted hyaluronic acid-gold nanorod platform with triple-stimuli responsiveness for photodynamic/photothermal therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2019 Jan; 83():400-413. PubMed ID: 30465921
[TBL] [Abstract][Full Text] [Related]
47. Rapid Decomposition and Catalytic Cascade Nanoplatforms Based on Enzymes and Mn-Etched Dendritic Mesoporous Silicon for MRI-Guided Synergistic Therapy.
Liu B; Wang Z; Li T; Sun Q; Dong S; Zhong C; Yang D; He F; Gai S; Yang P
ACS Appl Mater Interfaces; 2020 Oct; 12(41):45772-45788. PubMed ID: 32969221
[TBL] [Abstract][Full Text] [Related]
48. Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment.
Fan X; Wang K; Lu Q; Lu Y; Liu F; Li L; Li S; Ye H; Zhao J; Cao L; Zhang H; He Z; Sun J
Acta Biomater; 2022 Dec; 154():412-423. PubMed ID: 36280028
[TBL] [Abstract][Full Text] [Related]
49. A tumor-microenvironment fully responsive nano-platform for MRI-guided photodynamic and photothermal synergistic therapy.
Wang D; Zhang N; Jing X; Zhang Y; Xu Y; Meng L
J Mater Chem B; 2020 Sep; 8(36):8271-8281. PubMed ID: 32812996
[TBL] [Abstract][Full Text] [Related]
50. Photothermal MnO
Chen Z; Zhang Q; Huang Q; Liu Z; Zeng L; Zhang L; Chen X; Song H; Zhang J
Int J Pharm; 2022 Apr; 617():121578. PubMed ID: 35176333
[TBL] [Abstract][Full Text] [Related]
51. Near Infrared-Triggered Theranostic Nanoplatform with Controlled Release of HSP90 Inhibitor for Synergistic Mild Photothermal and Enhanced Nanocatalytic Therapy with Hypoxia Relief.
Tian B; Wang C; Du Y; Dong S; Feng L; Liu B; Liu S; Ding H; Gai S; He F; Yang P
Small; 2022 Jul; 18(28):e2200786. PubMed ID: 35661402
[TBL] [Abstract][Full Text] [Related]
52. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
[TBL] [Abstract][Full Text] [Related]
53. Colorectal Tumor Microenvironment-Activated Bio-Decomposable and Metabolizable Cu
Chang M; Hou Z; Jin D; Zhou J; Wang M; Wang M; Shu M; Ding B; Li C; Lin J
Adv Mater; 2020 Oct; 32(43):e2004647. PubMed ID: 32945002
[TBL] [Abstract][Full Text] [Related]
54. Hierarchical Responsive Nanoplatform with Two-Photon Aggregation-Induced Emission Imaging for Efficient Cancer Theranostics.
Ma B; Zhuang W; Xu H; Li G; Wang Y
ACS Appl Mater Interfaces; 2019 Dec; 11(50):47259-47269. PubMed ID: 31769279
[TBL] [Abstract][Full Text] [Related]
55. The application of nanoparticles in cancer immunotherapy: Targeting tumor microenvironment.
Yang M; Li J; Gu P; Fan X
Bioact Mater; 2021 Jul; 6(7):1973-1987. PubMed ID: 33426371
[TBL] [Abstract][Full Text] [Related]
56. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
[TBL] [Abstract][Full Text] [Related]
57. Design and Functionalization of the NIR-Responsive Photothermal Semiconductor Nanomaterials for Cancer Theranostics.
Huang X; Zhang W; Guan G; Song G; Zou R; Hu J
Acc Chem Res; 2017 Oct; 50(10):2529-2538. PubMed ID: 28972736
[TBL] [Abstract][Full Text] [Related]
58. Synergistic chemo-photothermal cancer therapy of pH-responsive polymeric nanoparticles loaded IR825 and DTX with charge-reversal property.
Wang X; Gu Y; Li Q; Xu Y; Shi Y; Wang Z; Xia M; Li J; Wang D
Colloids Surf B Biointerfaces; 2022 Jan; 209(Pt 2):112164. PubMed ID: 34735859
[TBL] [Abstract][Full Text] [Related]
59. Combined cancer therapeutics-Tackling the complexity of the tumor microenvironment.
Roma-Rodrigues C; Raposo LR; Valente R; Fernandes AR; Baptista PV
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2021 Sep; 13(5):e1704. PubMed ID: 33565269
[TBL] [Abstract][Full Text] [Related]
60. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
